Cargando…
Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma
BACKGROUND: The immune status within the tumor microenvironment has not been well determined in esophageal squamous cell carcinoma (ESCC). The aim of this study was to investigate the distributions of tumor-infiltrating T lymphocytes (TILs), and analyze their associations with clinical characteristi...
Autores principales: | Chen, Kaiyan, Zhu, Ziyu, Zhang, Nan, Cheng, Guoping, Zhang, Fanrong, Jin, Jiaoyue, Wu, Junzhou, Ying, Lisha, Mao, Weimin, Su, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687116/ https://www.ncbi.nlm.nih.gov/pubmed/28949934 http://dx.doi.org/10.12659/MSM.904154 |
Ejemplares similares
-
Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma
por: Chen, Kaiyan, et al.
Publicado: (2016) -
Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor‐κB signaling in esophageal squamous cell carcinoma
por: Wu, Junzhou, et al.
Publicado: (2017) -
The C-reactive protein/albumin ratio predicts long-term outcomes of patients with operable non-small cell lung cancer
por: Zhang, Fanrong, et al.
Publicado: (2016) -
Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma
por: Su, Dan, et al.
Publicado: (2019) -
CD103(+) tumor-infiltrating lymphocytes predict favorable prognosis in patients with esophageal squamous cell carcinoma
por: Chu, Yifan, et al.
Publicado: (2019)